Linking opioid use disorder treatment at STD clinics using buprenorphine
Official title: Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
Funded at Friends Research Institute, INC. · NIH-10771093 · Data updated 2026-11-12
This study is looking at the best ways to help people with opioid use disorder get the treatment they need when they visit public STD clinics, by trying out different methods to see which one helps them start and stick with their recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Friends Research Institute, INC. NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | April 15, 2019 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $559,848 |
| NIH project number | 5R01DA045724-05 |
| Project ID | NIH-10771093 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals seeking services at public STD clinics who are struggling with opioid use disorder.
✕Less likely to help
Patients who are not seeking treatment for opioid use disorder or who do not visit STD clinics may not benefit from this research.
What this research studies
This research investigates how to improve access to treatment for opioid use disorder (OUD) among patients visiting public STD clinics. It compares three different approaches: standard care, referral assistance through a Patient Navigator, and a combination of referral assistance with immediate access to buprenorphine treatment. The goal is to determine which method is most effective in helping patients enter and stay in OUD treatment. By focusing on high-risk populations in these clinics, the research aims to address a critical public health issue.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of patients receiving effective treatment for opioid use disorder.
How similar studies have gone: Previous research has shown that integrating substance use treatment into primary care settings can be effective, suggesting potential success for this approach in STD clinics.
Where this research is happening
-
Friends Research Institute, INC.
Baltimore, United States Active
Researchers
- Principal investigator: Gryczynski, Jan — Friends Research Institute, INC.
- Study coordinator: Gryczynski, Jan
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.